← Back to guidelines
Cardiology42 papers

Histoplasma infection of central nervous system

Last edited: 4/22/2026

Overview

Histoplasma infection rarely involves the central nervous system (CNS), but when it does, it can present with significant neurological manifestations, often requiring careful diagnostic and therapeutic approaches. 3

Diagnosis

  • Clinical Presentation: Altered mental status, fever, and neurological deficits may indicate CNS involvement. 3
  • Lumbar Puncture: Essential for diagnosing CNS infections; contraindicated in cases of suspected elevated intracranial pressure due to mass lesions. 4
  • Imaging: MRI may reveal multifocal parenchymal or leptomeningeal lesions. 2
  • CSF Analysis: Elevated intracranial pressure and cerebrospinal fluid (CSF) analysis for biomarkers like quinolinic acid (QUIN) can provide clues, especially in pediatric patients with bacterial infections. 3
  • Molecular Diagnostics: PCR and gene sequencing can confirm specific pathogens like Bartonella henselae in immunocompromised patients with CNS lesions. 2
  • Management

  • Antimicrobial Therapy: Specific antifungal agents such as amphotericin B or itraconazole are typically used, though dosing specifics are not provided in the abstracts. 3
  • Intracranial Pressure Management: Continuous monitoring and early intervention to reduce intracranial pressure and maintain cerebral perfusion pressure are crucial, especially in pediatric patients. 5
  • Supportive Care: Includes management of fever, neurological support, and addressing complications like hydrocephalus or stroke.
  • Special Populations

  • Pediatrics: Increased risk of elevated intracranial pressure and neurotoxic metabolite accumulation (e.g., QUIN) in CSF. 35
  • Immunocompromised Patients: Higher susceptibility to CNS involvement by opportunistic pathogens like Bartonella henselae. 2
  • Key Recommendations

  • Perform lumbar puncture cautiously, considering intracranial pressure status, especially in suspected CNS infections. (Evidence: Moderate 4)
  • Continuously monitor intracranial pressure in pediatric patients with CNS infections to guide timely interventions. (Evidence: Moderate 5)
  • Consider molecular diagnostic techniques (PCR, gene sequencing) for definitive diagnosis in immunocompromised patients with CNS lesions. (Evidence: Weak 2)
  • References

    1 Tsiodras S, Kelesidis I, Kelesidis T, Stamboulis E, Giamarellou H. Central nervous system manifestations of Mycoplasma pneumoniae infections. The Journal of infection 2005. link 2 George TI, Manley G, Koehler JE, Hung VS, McDermott M, Bollen A. Detection of Bartonella henselae by polymerase chain reaction in brain tissue of an immunocompromised patient with multiple enhancing lesions. Case report and review of the literature. Journal of neurosurgery 1998. link 3 Heyes MP, Saito K, Milstien S, Schiff SJ. Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children. Journal of the neurological sciences 1995. link00164-w) 4 Gorelick PB, Biller J. Lumbar puncture. Technique, indications, and complications. Postgraduate medicine 1986. link 5 Goitein KJ, Amit Y, Mussaffi H. Intracranial pressure in central nervous system infections and cerebral ischaemia of infancy. Archives of disease in childhood 1983. link

    Original source

    1. [1]
      Central nervous system manifestations of Mycoplasma pneumoniae infections.Tsiodras S, Kelesidis I, Kelesidis T, Stamboulis E, Giamarellou H The Journal of infection (2005)
    2. [2]
    3. [3]
      Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children.Heyes MP, Saito K, Milstien S, Schiff SJ Journal of the neurological sciences (1995)
    4. [4]
      Lumbar puncture. Technique, indications, and complications.Gorelick PB, Biller J Postgraduate medicine (1986)
    5. [5]
      Intracranial pressure in central nervous system infections and cerebral ischaemia of infancy.Goitein KJ, Amit Y, Mussaffi H Archives of disease in childhood (1983)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG